Issued Patents 2024
Showing 1–25 of 25 patents
| Patent # | Title | Co-Inventors | Date |
|---|---|---|---|
| 12129267 | Heteroaryl amide compounds as sting activators | Liangxing Wu, Neil Lajkiewicz | 2024-10-29 |
| 12122767 | Bicyclic heterocycles as FGFR inhibitors | Oleg Vechorkin, Hai Fen Ye | 2024-10-22 |
| 12084449 | Imidazotriazines and imidazopyrimidines as kinase inhibitors | Jincong Zhuo, Meizhong Xu, Chunhong He, Colin Zhang, Ding-Quan Qian +3 more | 2024-09-10 |
| 12083124 | Bicyclic heterocycles as FGFR inhibitors | Oleg Vechorkin, Minh Ngoc Nguyen, Chao Qi, Anlai Wang, Michael Witten +4 more | 2024-09-10 |
| 12077539 | Imidazole and triazole KRAS inhibitors | Chao Qi, Xiaozhao Wang | 2024-09-03 |
| 12060433 | CD73 inhibitor and A2A/A2B adenosine receptor inhibitor combination therapy | Horacio G. Nastri, Shaun M. Stewart, Juan Carlos Almagro, Jing Zhou, Rebecca A. Buonpane +9 more | 2024-08-13 |
| 12030883 | Hetero-tricyclic compounds as inhibitors of KRAS | Peter Carlsen, Ken Mukai, Haolin Yin, Xiaozhao Wang, Wenyu Zhu | 2024-07-09 |
| 12030889 | Imidazopyridazine and imidazopyridine compounds and uses thereof | Jun Pan, Jeremy Roach, Song Mei, Chunhong He, Liangxing Wu | 2024-07-09 |
| 12030884 | Pyrazoloquinoline KRAS inhibitors | Wenyu Zhu, Xiaozhao Wang | 2024-07-09 |
| 12012409 | Bicyclic heterocycles as FGFR inhibitors | Jeremy Roach, Artem Shvartsbart, Michael Witten | 2024-06-18 |
| 11999752 | Vinyl imidazole compounds as inhibitors of KRAS | Peter Carlsen, Xiaozhao Wang, Alexander Sokolsky, Pei Gan, Rocco Policarpo | 2024-06-04 |
| 11999740 | Fused pyrazine derivatives as A2A / A2B inhibitors | Xiaozhao Wang, Peter Carlsen, Pei Gan, Gia Hoang, Yong Li +3 more | 2024-06-04 |
| 11958861 | Spirocyclic lactams as JAK2 V617F inhibitors | Stacey Shepard, Charles Cole, Nikoo Falahatpisheh, Kai Liu, Lixin Shao +3 more | 2024-04-16 |
| 11939328 | Quinoline compounds as inhibitors of KRAS | Qinda Ye, Matthew S. McCammant, Artem Shvartsbart, Wenyu Zhu, Bin Hu +3 more | 2024-03-26 |
| 11939331 | Tricyclic heterocycles as FGFR inhibitors | Xin Li, Evan Styduhar, Robert Swyka, Oleg Vechorkin | 2024-03-26 |
| 11919908 | Substituted pyrrolo[2,3-d]pyrimidine compounds as JAK2 V617F inhibitors | Andrew W. Buesking, Onur Atasoylu, Cheng-Tsung Lai, Padmaja Polam, Liangxing Wu | 2024-03-05 |
| 11919904 | Sulfonylamide compounds as CDK2 inhibitors | Alexander Sokolsky, Sarah Winterton, Liangxing Wu, Min Ye, Yingnan Chen +2 more | 2024-03-05 |
| 11912722 | Tricyclic heteroaryl compounds as sting activators | Liangxing Wu, Yingda Ye | 2024-02-27 |
| 11897891 | Tricyclic heterocycles as FGFR inhibitors | Matthew S. McCammant, Evan Styduhar, Oleg Vechorkin, Robert Swyka | 2024-02-13 |
| 11891388 | Pyrazolopyridine compounds and uses thereof | Kai Liu, Jun Pan, Alexander Sokolsky, Oleg Vechorkin, Hai Fen Ye +1 more | 2024-02-06 |
| 11873309 | Heterocyclic compounds as immunomodulators | Kaijiong Xiao, Fenglei Zhang, Liangxing Wu | 2024-01-16 |
| 11873304 | Fused pyrimidine derivatives as A2A/A2B inhibitors | Xiaozhao Wang, Heeoon Han, Matthew S. McCammant, Liangxing Wu, Zhiyong Yu +1 more | 2024-01-16 |
| 11866432 | Dihydropyrido[2,3-d]pyrimidinone compounds as CDK2 inhibitors | Alexander Sokolsky, Liangxing Wu | 2024-01-09 |
| 11866435 | Heterocyclic compounds as immunomodulators | Neil Lajkiewicz, Liangxing Wu | 2024-01-09 |
| 11866426 | Benzothiazole compounds and uses thereof | Joshua Hummel, Oleg Vechorkin, Alexander Sokolsky, Qinda Ye, Kai Liu | 2024-01-09 |